Ignite Creation Date:
2025-12-24 @ 4:37 PM
Ignite Modification Date:
2026-02-22 @ 5:23 PM
Study NCT ID:
NCT01902966
Status:
TERMINATED
Last Update Posted:
2021-10-12
First Post:
2013-07-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Feasibility - Beta Adrenergic Blockade (BB) in Cervical Cancer (CX)
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-09-11
Start Date Type:
ACTUAL
Primary Completion Date:
2020-08-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-08-14
Completion Date Type:
ACTUAL
First Submit Date:
2013-07-12
First Submit QC Date:
None
Study First Post Date:
2013-07-18
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2021-07-08
Results First Submit QC Date:
None
Results First Post Date:
2021-10-12
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-09-15
Last Update Post Date:
2021-10-12
Last Update Post Date Type:
ACTUAL